Terms: = Endocrine gland cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Treatment
25 results:
1. Thyroid cancer Survival in the Multiethnic Cohort Study.
Abe JV; Park SY; Haiman CA; Cheng I; Le Marchand L; Hernandez BY; Wilkens LR
Int J Environ Res Public Health; 2024 Mar; 21(3):. PubMed ID: 38541323
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer.
Lai SP; Wang SY; Chan AL; Leung JH; Yip HT
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):541-549. PubMed ID: 38372034
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy and toxicity of mirvetuximab soravtansine, a novel antibody-drug conjugate, in the treatment of advanced or recurrent ovarian cancer: a meta-analysis.
Xu K; Wang T; Pan S; He J
Expert Rev Clin Pharmacol; 2023; 16(11):1141-1152. PubMed ID: 37771164
[TBL] [Abstract] [Full Text] [Related]
4. Effect of pituitary-dependent hypercortisolism on the survival of dogs treated with radiotherapy for pituitary macroadenomas.
Rapastella S; Morabito S; Sharman M; Benoit J; Schiavo L; Morris J; Dobson JM; Scudder CJ
J Vet Intern Med; 2023; 37(4):1331-1340. PubMed ID: 37218395
[TBL] [Abstract] [Full Text] [Related]
5. Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma.
Ecker BL; Tao AJ; Janssen QP; Walch HS; Court CM; Balachandran VP; Crane CH; D'Angelica MI; Drebin JA; Kingham TP; Soares KC; Iacobuzio-Donahue CA; Vakiani E; Gonen M; O'Reilly EM; Varghese AM; Jarnagin WR; Wei AC
Clin Cancer Res; 2023 Apr; 29(7):1368-1374. PubMed ID: 36795432
[TBL] [Abstract] [Full Text] [Related]
6. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms.
Nießen A; Schimmack S; Lewosinska M; Hinz U; Bechtiger FA; Hackert T; Büchler MW; Strobel O
Surgery; 2022 Dec; 172(6):1791-1799. PubMed ID: 36180252
[TBL] [Abstract] [Full Text] [Related]
7. Preoperative predictors for early and very early disease recurrence in patients undergoing resection of pancreatic ductal adenocarcinoma.
Daamen LA; Dorland G; Brada LJH; Groot VP; van Oosten AF; Besselink MG; Bosscha K; Bonsing BA; Busch OR; Cirkel GA; van Dam RM; Festen S; Groot Koerkamp B; Haj Mohammad N; van der Harst E; de Hingh IHJT; Intven MPW; Kazemier G; Los M; de Meijer VE; Nieuwenhuijs VB; Roos D; Schreinemakers JMJ; Stommel MWJ; Verdonk RC; Verkooijen HM; Molenaar IQ; van Santvoort HC;
HPB (Oxford); 2022 Apr; 24(4):535-546. PubMed ID: 34642090
[TBL] [Abstract] [Full Text] [Related]
8. treatment Strategies for Dopamine Agonist-Resistant and Aggressive Prolactinomas: A Comprehensive Analysis of the Literature.
Sari R; Altinoz MA; Ozlu EBK; Sav A; Danyeli AE; Baskan O; Er O; Elmaci I
Horm Metab Res; 2021 Jul; 53(7):413-424. PubMed ID: 34282593
[TBL] [Abstract] [Full Text] [Related]
9. Laparoscopic distal pancreatectomy in patients with poor physical status.
Sahakyan MA; Tholfsen T; Kleive D; Waage A; Buanes T; Labori KJ; Røsok BI; Edwin B
HPB (Oxford); 2021 Jun; 23(6):877-881. PubMed ID: 33092964
[TBL] [Abstract] [Full Text] [Related]
10. Recent malignant testicular tumor trend in Japan, a country with an aging population: a large-scale study of 2012-2015 hospital-based cancer registry data.
Kojo K; Kawai K; Kawahara T; Kimura T; Kandori S; Nagumo Y; Nitta S; Kojima T; Okuyama A; Higashi T; Nishiyama H
Jpn J Clin Oncol; 2020 Sep; 50(10):1201-1208. PubMed ID: 32627833
[TBL] [Abstract] [Full Text] [Related]
11. Incidental Congestive Heart Failure in Patients With Aldosterone-Producing Adenomas.
Huang WC; Chen YY; Lin YH; Chen L; Lin PC; Lin YF; Liu YC; Wu CH; Chueh JS; Chu TS; Wu KD; Huang CY; Wu VC; ;
J Am Heart Assoc; 2019 Dec; 8(24):e012410. PubMed ID: 31801414
[TBL] [Abstract] [Full Text] [Related]
12. The prophylactic effects of long-acting granulocyte colony-stimulating factor for febrile neutropenia in newly diagnosed patients with epithelial ovarian cancer: a randomised controlled study.
Li L; Ma S; Wu M; Tan X; Zhong S; Lang J
BMJ Support Palliat Care; 2019 Dec; 9(4):373-380. PubMed ID: 31467066
[TBL] [Abstract] [Full Text] [Related]
13. The Role of Disease Label in Patient Perceptions and treatment Decisions in the Setting of Low-Risk Malignant Neoplasms.
Dixon PR; Tomlinson G; Pasternak JD; Mete O; Bell CM; Sawka AM; Goldstein DP; Urbach DR
JAMA Oncol; 2019 Jun; 5(6):817-823. PubMed ID: 30896738
[TBL] [Abstract] [Full Text] [Related]
14. Oncologic outcomes after robot-assisted versus laparoscopic distal pancreatectomy: Analysis of the National cancer Database.
Raoof M; Nota CLMA; Melstrom LG; Warner SG; Woo Y; Singh G; Fong Y
J Surg Oncol; 2018 Sep; 118(4):651-656. PubMed ID: 30114321
[TBL] [Abstract] [Full Text] [Related]
15. Cost-effectiveness analysis in papillary thyroid carcinoma patients with different neck dissection strategy: A retrospective cohort study.
Guo K; Zheng X; Li D; Wu Y; Ji Q; Wang Z
Int J Surg; 2018 Feb; 50():1-5. PubMed ID: 29278752
[TBL] [Abstract] [Full Text] [Related]
16. Main-duct Intraductal Papillary Mucinous Neoplasm: High cancer Risk in Duct Diameter of 5 to 9 mm.
Hackert T; Fritz S; Klauss M; Bergmann F; Hinz U; Strobel O; Schneider L; Büchler MW
Ann Surg; 2015 Nov; 262(5):875-80; discussion 880-1. PubMed ID: 26583679
[TBL] [Abstract] [Full Text] [Related]
17. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer.
Kelemen LE; Warren GW; Koziak JM; Köbel M; Steed H
Gynecol Oncol; 2016 Jan; 140(1):124-30. PubMed ID: 26549109
[TBL] [Abstract] [Full Text] [Related]
18. Independent radiologic review: bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer.
Aghajanian C; Goff B; Nycum LR; Wang Y; Husain A; Blank S
Gynecol Oncol; 2014 Apr; 133(1):105-10. PubMed ID: 24508841
[TBL] [Abstract] [Full Text] [Related]
19. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
Parasramka MA; Ali S; Banerjee S; Deryavoush T; Sarkar FH; Gupta S
Mol Nutr Food Res; 2013 Feb; 57(2):235-48. PubMed ID: 23293055
[TBL] [Abstract] [Full Text] [Related]
20. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.
Aghajanian C; Blank SV; Goff BA; Judson PL; Teneriello MG; Husain A; Sovak MA; Yi J; Nycum LR
J Clin Oncol; 2012 Jun; 30(17):2039-45. PubMed ID: 22529265
[TBL] [Abstract] [Full Text] [Related]
[Next]
